Man’s best friend: Common canine virus may lead to new vaccines for deadly human diseases

He, Biao-v.portrait

November 27, 2012

Print
Share    
Writer:
James Hataway

James Hataway

PR Coordinator

Recent and archived articles by James Hataway

OVPR
Research, Office of the Vice President for (OVPR)
Work: 706-542-5222
Email:

Contact:
Biao He

Biao He

Professor

Department of Infectious Diseases
Infectious Diseases, Department ofFaculty of Infectious Diseases
Work: 706/542-2855
Email:
,

Photography

  • magnify He, Biao-v.portrait

    Biao He is a professor of infectious diseases and a Georgia Research Alliance distinguished investigator in the College of Veterinary Medicine.

Scroll Left 1 Scroll Right

Related Sites

Athens, Ga. - Researchers at the University of Georgia have discovered that a virus commonly found in dogs may serve as the foundation for the next great breakthrough in human vaccine development.

Although harmless in humans, parainfluenza virus 5, or PIV5, is thought to contribute to upper respiratory infections in dogs, and it is a common target for canine vaccines designed to prevent kennel cough. In a paper published recently in PLOS ONE, researchers describe how this virus could be used in humans to protect against diseases that have eluded vaccine efforts for decades.

"We can use this virus as a vector for all kinds of pathogens that are difficult to vaccinate against," said Biao He, the study's principal investigator and professor of infectious diseases in UGA's College of Veterinary Medicine. "We have developed a very strong H5N1 flu vaccine with this technique, but we are also working on vaccines for HIV, tuberculosis and malaria."

PIV5 does not cause disease in humans, as our immune system is able to recognize and destroy it. By placing antigens from other viruses or parasites inside PIV5, it effectively becomes a delivery vehicle that exposes the human immune system to important pathogens and allows it to create the antibodies that will protect against future infection.

This approach not only ensures full exposure to the vaccine but also is much safer because it does not require the use of attenuated, or weakened, pathogens. For example, an HIV vaccine delivered by PIV5 would contain only those parts of the HIV virus necessary to create immunity, making it impossible to contract the disease from the vaccine.

"Safety is always our number one concern," said He, who is also a Georgia Research Alliance distinguished investigator and member of the Faculty of Infectious Diseases. "PIV5 makes it much easier to vaccinate without having to use live pathogens."

Using viruses as a delivery mechanism for vaccines is not a new technique, but previous efforts have been fraught with difficulty. If humans or animals already possess a strong immunity to the virus used for delivery, the vaccine is unlikely to work, as it will be destroyed by the immune system too quickly.

"Pre-existing immunity to viruses is the main reason most of these vaccines fail," He said.

But in this latest study, He and his colleagues demonstrate that immunity to PIV5 does not limit its effectiveness as a vaccine delivery mechanism, even though many animals-including humans- already carry antibodies against it.

In their experiments, the researchers found that a single dose inoculation using PIV5 protected mice from the influenza strain that causes seasonal flu. Another single dose experimental vaccine also protected mice from the highly pathogenic and deadly H5N1 virus commonly known as bird flu.

This recent work is a culmination of more than fifteen years of research and experimentation with the PIV5 virus, and He has confidence that it will serve as an excellent foundation for vaccines to treat diseases in both animals and humans.

"I believe we have the best H5N1 vaccine candidate in existence," He said. "But we have also opened up a big field for a host of new vaccines."

UGA Faculty of Infectious Diseases
The University of Georgia Faculty of Infectious Diseases was created in 2007 to address existing and emerging infectious disease threats more effectively by integrating multidisciplinary research in animal, human and ecosystem health. Researchers from across the university focus on epidemiology, host-pathogen interactions, the evolution of infectious diseases, disease surveillance and predictors and the development of countermeasures such as vaccines, therapeutics and diagnostics. For more information about the Faculty of Infectious Diseases, see fid.ovpr.uga.edu.

UGA College of Veterinary Medicine
The UGA College of Veterinary Medicine, founded in 1946, is dedicated to training future veterinarians, to conducting research related to animal and human diseases, and to providing veterinary services for animals and their owners. Research efforts are aimed at enhancing the quality of life for animals and people, improving the productivity of poultry and livestock, and preserving a healthy interface between wildlife and people in the environment they share. The college enrolls 102 students each fall out of more than 800 who apply.

 

Filed under: Medical Science, Health Sciences, Infectious Diseases, Pharmaceuticals, University News

News Service

Director
Cynthia Hoke

706 / 542-8083
Public Relations Coordinator
Stephanie Schupska

706 / 542-6927
Public Relations Coordinator
Sara Freeland

706 / 542-8077
Science Writer
April Sorrow

706 / 542-7991

Broadcast, Video and Photography

Director
Steve Bell

706 / 542-8089
Broadcast Coordinator
Pete Konenkamp

706 / 542-8080
Photography
Rick O‘Quinn

706 / 542-8085